CONVENTIONAL VS CONTROLLED-RELEASE CARBAMAZEPINE - A MULTICENTER, DOUBLE-BLIND, CROSS-OVER STUDY

被引:0
|
作者
CANGER, R
ALTAMURA, AC
BELVEDERE, O
MONACO, F
MONZA, GC
MUSCAS, GC
MUTANI, R
PANETTA, B
PISANI, F
ZACCARA, G
ZAGNONI, PG
机构
[1] UNIV SASSARI, DEPT NEUROL, I-07100 SASSARI, ITALY
[2] UNIV FLORENCE, DEPT NEUROL, I-50121 FLORENCE, ITALY
[3] UNIV TURIN, DEPT NEUROL, NOVARA, ITALY
[4] UNIV MESSINA, DEPT NEUROL, I-98100 MESSINA, ITALY
[5] SANTA CROCE HOSP, DEPT NEUROL, CUNEO, ITALY
[6] UNIV MILAN, DEPT PSYCHIAT, I-20122 MILAN, ITALY
来源
ACTA NEUROLOGICA SCANDINAVICA | 1990年 / 82卷 / 01期
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:9 / 13
页数:5
相关论文
共 50 条
  • [1] A DOUBLE-BLIND COMPARISON OF CONVENTIONAL AND CONTROLLED-RELEASE CARBAMAZEPINE IN HEALTHY-SUBJECTS
    LARKIN, JG
    MCLELLAN, A
    MUNDAY, A
    SUTHERLAND, M
    BUTLER, E
    BRODIE, MJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (03) : 313 - 322
  • [2] MONOTHERAPY WITH CONVENTIONAL AND CONTROLLED-RELEASE CARBAMAZEPINE - A DOUBLE-BLIND, DOUBLE-DUMMY COMPARISON IN EPILEPTIC PATIENTS
    MCKEE, PJW
    BLACKLAW, J
    BUTLER, E
    GILLHAM, RA
    BRODIE, MJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (01) : 99 - 104
  • [3] Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain
    Bruera, E
    Belzile, M
    Pituskin, E
    Fainsinger, R
    Darke, A
    Harsanyi, Z
    Babul, N
    Ford, I
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3222 - 3229
  • [4] Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study
    M Bartolini
    MA Giamberardino
    C Lisotto
    P Martelletti
    D Moscato
    B Panascia
    L Savi
    LA Pini
    G Sances
    P Santoro
    G Zanchin
    S Omboni
    MD Ferrari
    B Fierro
    F Brighina
    The Journal of Headache and Pain, 2013, 14
  • [5] Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study
    Bartolini, M.
    Giamberardino, M. A.
    Lisotto, C.
    Martelletti, P.
    Moscato, D.
    Panascia, B.
    Savi, L.
    Pini, L. A.
    Sances, G.
    Santoro, P.
    Zanchin, G.
    Omboni, S.
    Ferrari, M. D.
    Fierro, B.
    Brighina, F.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [6] A DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF CONTROLLED-RELEASE REMOXIPRIDE, IMMEDIATE-RELEASE REMOXIPRIDE AND HALOPERIDOL IN SCHIZOPHRENIA
    HEBENSTREIT, GF
    LAUX, G
    SCHUBERT, H
    BECKMANN, H
    AMMAN, J
    BUNSE, J
    EIKMEIER, G
    GERETSEGGER, C
    KANITZ, RD
    KANZOW, WT
    KONIG, P
    MAIR, M
    MAYR, H
    PLATZ, T
    RITTMANNSBERGER, H
    SCHONY, HW
    STRUCK, M
    VISKIHANKA, Z
    WIBMER, M
    ZOCHLING, R
    PHARMACOPSYCHIATRY, 1991, 24 (05) : 153 - 158
  • [7] LAMOTRIGINE THERAPY FOR PARTIAL SEIZURES - A MULTICENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSS-OVER TRIAL
    MESSENHEIMER, J
    RAMSAY, RE
    WILLMORE, LJ
    LEROY, RF
    ZIELINSKI, JJ
    MATTSON, R
    PELLOCK, JM
    VALAKAS, AM
    WOMBLE, G
    RISNER, M
    EPILEPSIA, 1994, 35 (01) : 113 - 121
  • [9] Levosulpiride in somatoform disorders: A double-blind, placebo-controlled cross-over study
    Altamura, AC
    Di Rosa, A
    Ermentini, A
    Guaraldi, GP
    Invernizzi, G
    Rudas, N
    Tacchini, G
    Pioli, R
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (03) : 155 - 159
  • [10] Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
    Amiaz, Revital
    Fostick, Leah
    Gershon, Ari
    Zohar, Joseph
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (06) : 455 - 461